PTE Summarize Written Text Task Sample 199

Read the passage below and summarize it using one sentence. Type your response in the box at the bottom of the screen. You have 10 minutes to finish this task. Your response will be judged on the quality of your writing and on how well your response presents the key points in the passage.

The Ethical Dilemma of Pharmaceutical Marketing by Medical Professionals

The issue of whether medical professionals should be allowed to market pharmaceuticals to their patients is fraught with ethical considerations. On one hand, proponents argue that medical professionals are best positioned to provide accurate information about medications, ensuring that patients make informed decisions about their health. Pharmaceutical marketing may also serve as a valuable educational tool, raising awareness about treatment options and advancements in medicine.

However, allowing medical professionals to engage in pharmaceutical marketing raises concerns about conflicts of interest and patient autonomy. Pharmaceutical companies often incentivize healthcare providers to promote their products, potentially compromising the integrity of medical advice and undermining patient trust. Moreover, the influence of pharmaceutical marketing may lead to overprescribing or inappropriate medication choices, prioritizing profit over patient well-being.

Furthermore, pharmaceutical marketing may exacerbate healthcare disparities by disproportionately targeting patients with higher socioeconomic status or access to healthcare resources. This can widen existing inequities in healthcare access and contribute to unnecessary healthcare spending.

In conclusion, while pharmaceutical marketing by medical professionals may have potential benefits in terms of education and information dissemination, the ethical considerations outweigh the advantages. To uphold patient trust, autonomy, and safety, it is imperative to establish clear guidelines and regulations to mitigate the influence of pharmaceutical marketing on medical practice. Prioritizing evidence-based medicine and unbiased patient-centered care should remain the cornerstone of medical practice, free from undue influence from pharmaceutical companies.


The ethical dilemma of allowing medical professionals to market pharmaceuticals raises concerns about conflicts of interest, patient autonomy, and healthcare disparities, highlighting the need for clear regulations to uphold patient trust and safety while ensuring unbiased, evidence-based medical practice.